Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Tables)

v3.21.2
Stock-Based Compensation and Other Benefit Plans (Tables)
9 Months Ended
Sep. 30, 2021
Stock-Based Compensation and Other Benefit Plans [Abstract]  
Summary of Stock-Based Compensation

Three Months Ended September 30,

Nine Months Ended September 30,

2021

2020

2021

2020

(in thousands)

Stock-based compensation - equity awards

$

327

$

322

$

767

$

527

Stock-based compensation - liability awards

(302)

(570)

1,331

(2,624)

Total stock-based compensation

$

25

$

(248)

$

2,098

$

(2,097)

Stock Option Valuation Assumptions

Nine Months Ended September 30,

2021

2020

Weighted average exercise price - ($/share)

$

3.14

$

1.23

Expected life in years

6.0

6.0

Average expected volatility

75

%

74

%

Risk-free interest rate

0.95

%

0.42

%

Weighted average grant date fair value - ($/share)

$

2.07

$

0.79

Stock Option Activity Stock option activity associated with the Monte Carlo model for the nine months ended September 30, 2021 is provided below:

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

644

$

1.23

Granted

402

3.14

Exercised

Unvested shares forfeited

(687)

1.96

Vested shares expired

Outstanding at September 30, 2021

359

$

1.96

9.00

$

378

Exercisable at September 30, 2021

74

$

1.23

8.74

$

126

Stock option activity associated with the Black-Scholes model for the nine months ended September 30, 2021 is provided below:

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

1,804

$

1.38

Granted

Exercised

(1,088)

1.20

Unvested shares forfeited

(64)

2.33

Vested shares expired

Outstanding at September 30, 2021

652

$

1.60

1.73

$

876

Exercisable at September 30, 2021

555

$

1.47

1.61

$

816

Summary of Non Vested Awards

Restricted Stock

Weighted Average Grant Date Fair Value

(in thousands)

Non-vested shares outstanding at January 1, 2021

1,155

$

1.30

Awards granted

605

3.13

Awards vested

(543)

1.28

Awards forfeited

(462)

2.00

Non-vested shares outstanding at September 30, 2021

755

$

2.36

SAR Activity

Number of Shares Underlying SARs

Weighted Average Exercise Price Per Share

Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

2,940

$

1.33

Granted

Exercised

(2,306)

1.16

Unvested SARs forfeited

(125)

2.33

Vested SARs expired

Outstanding at September 30, 2021

509

$

1.83

2.23

$

567

Exercisable at September 30, 2021

338

$

1.69

2.10

$

423